Back to Company Profile
Alpha

Alpha Profiles · Company Profile

Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease.

https://registry.alpha.ac/companies/acumen-pharmaceuticals-inc

Acumen Pharmaceuticals, Inc. logo
Entity
Public listing published
Primary listing
NASDAQ: ABOS
Verification
Partially verified
Last reviewed
2026-09-12T21:32:05.800844+00:00

Overview

Acumen Pharmaceuticals Inc. operates as a biopharmaceutical entity in the clinical development stage, dedicated to discovering and advancing therapeutic solutions for Alzheimer's disease. A key focus for the company involves progressing ACU193, an investigational targeted immunotherapy drug candidate. This particular humanized monoclonal antibody is currently undergoing initial human testing in Phase I clinical trials, where it is designed to specifically target soluble amyloid-beta oligomers. T

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

0 public records

Executive roster coverage is NOT_ASSERTED. An empty list is not evidence that this company has no executive team.

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 12, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.

Board roles

2 public records

Source record

Alpha canonical company public projection

Supports Company identity, Published leadership, Entity status boundary

Reviewed 2026-09-12T21:32:05.800844+00:00

Generated 2026-09-13T03:23:19.189Z

Data as of 2026-09-12T21:32:05.800844+00:00

https://registry.alpha.ac/companies/acumen-pharmaceuticals-inc